Inspire Investing’s RxSight RXST Stock Holding History

Inspire Investing’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,016	Closed	-$843K	–	892
2024 Q2	$843K	Sell	14,016 -3,771	-21%	-$216K	0.1%	230
2024 Q1	$917K	Buy	+17,787	New	+$873K	0.09%	222

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Inspire Investing's RXST Position: Q3 2024 in Review

Inspire Investing sold out of RxSight (RXST) in Q3 2024, closing a stake of 14,016 shares — an estimated $843K sold.

Inspire Investing first reported a position in RXST in Q1 2024 and held it in 2 quarters. The position peaked at $917K in Q1 2024. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

Inspire Investing reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
Inspire Investing sold 14,016 RxSight shares in Q3 2024, an estimated $843K.
Inspire Investing first reported a position in RxSight in Q1 2024 and held it in 2 quarters.
Inspire Investing's RxSight position peaked at $917K in Q1 2024.
214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on Inspire Investing's 13F filing for Q3 2024, filed 10 Oct 2024.